Skip to content

EFFECTIVENESS OF TELENUTRITION EDUCATION, GROUP LIFESTYLE BALANCE PROGRAM, FOR WEIGHT LOSS AND IMPROVEMENT IN DIETARY PATTERN AMONG MYANMAR ADULTS WITH OVERWEIGHT AND OBESITY

EFFECTIVENESS OF TELENUTRITION EDUCATION, GROUP LIFESTYLE BALANCE PROGRAM, FOR WEIGHT LOSS AND IMPROVEMENT IN DIETARY PATTERN AMONG MYANMAR ADULTS WITH OVERWEIGHT AND OBESITY

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
TCTR
Registry ID
TCTR20230508001
Enrollment
28
Registered
2023-05-08
Start date
2022-07-03
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Overweight and obesity in Myanmar adults with no underlying comorbid diesases Obesity Lifestyle therapy Behavioural therapy

Interventions

The protocol of this study followed the Group Lifestyle Balance,GLB, protocol, which was developed at the University of Pittsburgh. The original Lifestyle intervention program of Diabetes Prevention P
Experimental Behavioral
Group lifestyle education via telenutrition for weight loss and dietary pattern improvement

Sponsors

Nyan Hlaing Bwar
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 55 Years

Inclusion criteria

Inclusion criteria: 1. Myanmar adults aged 20-55 years 2. BMI 25 kg/m2 and above 3. Must have an either smartphone/laptop/iPad/tablet with a video conferencing platform and Internet Connection. 4. Must be able to use Internet, E-mail, video conferencing platform

Exclusion criteria

Exclusion criteria: 1. Any underlying medical illness which will encompass diabetes , cardiovascular diseases, hypertension, any types of cancer, any active renal and hepatic diseases, any active pulmonary diseases, any serious gastrointestinal diseases such as pancreatitis, inflammatory bowel disease, and any endocrine disorders e.g., Thyroid disease, phaeochromocytoma, Cushing's syndrome, etc. 2. Recent abdominal, thoracic, neuro, and orthopaedic surgery which may affect the intervention. 3. Being pregnant or lactating 4. Major psychotic disorders which may interfere with intervention including but not limited to depression, anxiety disorder, schizophrenia, bipolar disorder, etc. 5. People currently taking medications for weight loss e.g. orlistat, liraglutide, semaglutide, bupropion/naltrexone, people following certain diet plans or serious food allergies which may interfere with the intervention, e.g. ketogenic diet, renal diet, and people with more than 10% of weight loss in past 6 months

Design outcomes

Primary

MeasureTime frame
Body weight weekly up to 11th week Weighing scale,Vegetables and fruits intake weekly up to 11th week 3-days food record,Saturated fat intake 12th week at the end of intervention 3-day food record and INMUCAL software 4.0,Energy intake weekly up to 11th week 3-day food record and INMUCAL software 4.0,People who achieve weight loss 7% at the end of intervention (%) 12 th week at the end of intervention Weighing scale,People who achieve 5% weight loss at the end of intervention (%) 12th at the end of intervention Weighing scale ,People who achieve total fat intake less than 25% and saturated fat intake less than 10% at the end of intervention (%) 12th week at the end of intervention 3-day food record and INMUCAL software 4.0,People who achieve physical goals at the end of intervention (%) 12th week at the end of intervention daily physical activity monitor booklet

Secondary

MeasureTime frame
Food Group Diversity Score 12th week at the end of intervention Diet Quality Questionnaire (DQQ),Participants who attend at least half of the classes (%) 12th week at the end of intervention attendance record

Countries

Thailand

Contacts

Public ContactNyan Bwar

Institute of Nutrition, Mahidol University

nyanhlaingbwar96@gmail.com0929597705

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026